Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-24 @ 7:50 PM
NCT ID:
NCT07160504
Eligibility Criteria:
Inclusion Criteria:
* Postmenopausal women aged ≥ 50
* Symptomatic vaginal atrophy
* Indication for standard treatment with vaginal estrogen tablets 10 µg at least three times a week
* Study population 1: without a history of venous thromboembolic event
* Study population 2: with a history of venous thromboembolic event
Exclusion Criteria:
* Unable to give written informed consent
* Does not speak Danish
* Current cancer treatment
* Current treatment with blood thinning medication (except plateletinhibitor)
* Current treatment with local or systematic estrogen
* Systemic inflammatory disease, liver disease or kidney disease
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
50 Years
Study:
NCT07160504
Study Brief:
Protocol Section:
NCT07160504